Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT
13F Institute Ownership
Total Institutes of 35 in Gain Therapeutics expanded their positions with an increase of 8 investors compared to the previous quarter. An additional 827.06K shares, as total invested capital grew by $559.74K with ownership percentage increasing from 7.48% to 9.80%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.036
1.04
Call Flow 8,400
49%
Put Flow 8,700
51%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Dme Capital Management, LP | 1.97% | 566.13K | +0.00% | 1.08M | 0.05% | May 15, 2025 |
| Jones Financial Companies Lllp | 1.49% | 427.7K | +335.32% | 808.35K | < 0.01% | May 28, 2025 |
| Geode Capital Management, LLC | 0.98% | 282.21K | +5.53% | 539.09K | < 0.01% | May 13, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.